FDA Adverse Event Injury Summary report: N

PULSE GEN MODEL 100

MDR report key: 1400101 · Received June 5, 2009

Report

Report Number
1644487-2009-01145
Event Type
Injury
Date Received
June 5, 2009
Date of Event
September 26, 2000
Report Date
May 28, 2009
Manufacturer
CYBERONICS, INC.
Product Code
LYJ
PMA / PMN Number
P970003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ARTICLE CITATION: KOUTROUMANIDIS, MICHAEL, MICHAEL J. HENNESSY, COLIN D. BINNIE, AND CHARLES E. POLKEY. "AGGRAVATION OF PARTIAL EPILEPSY AND EMERGENCE OF NEW SEIZURE TYPE DURING TREATMENT WITH VNS." NEUROLOGY 55 (2000): 892-93.

Description of Event or Problem · 1

IT WAS REPORTED IN A SCIENTIFIC ARTICLE THAT A VNS PATIENT, WHO HAD INITIALLY RESPONDED TO VNS THERAPY, BEGAN TO EXPERIENCE AN "ABRUPT WORSENING OF HER EPILEPSY" AFTER INCREASING HER THERAPY OUTPUT CURRENT BY 0.25MA (2.25MA TO 2.50MA). THE AUTHOR INDICATED THAT THIS WORSENED SEIZURE ACTIVITY CONSISTED OF AN INCREASE IN SEIZURE FREQUENCY, ABOVE PRE-VNS BASELINE LEVELS, AS WELL AS THE DEVELOPMENT OF A NEW SEIZURE TYPE. THE ARTICLE STATES THAT THE PATIENT HAD "NO HISTORY OF RECENT AED CHANGES OR DOSE OMISSION, PROTRACTED SLEEP DEPRIVATION, STRESSFUL EVENTS, TRAUMA, OR INTERVENING INFECTION COULD BE ELICITED AND BOTH THE GENERATOR AND THE LEAD WERE FUNCTIONING NORMALLY". THE AUTHOR STATES THAT ONCE THE PATIENT'S NCP DEVICE WAS PROGRAMMED OFF, "2 DAYS LATER THE NEW SEIZURE TYPE CEASED AND THE PATIENT'S HABITUAL SEIZURES SETTLED DOWN TO PRE-IMPLANTATION BASELINE." IN LIGHT OF THESE EVENTS, THE PT'S DEVICE WAS REPORTEDLY PROGRAMMED BACK ON A MONTH LATER DUE TO THE INITIAL EFFICACY SHE HAD RECEIVED FROM VNS THERAPY. THE PT'S OUTPUT CURRENT WAS GRADUALLY INCREASED UP TO 1.75MA AND AFTER SIX MONTHS OF FOLLOW UP, THE PATIENT REPORTEDLY REGAINED THE EFFICACY THAT SHE HAD INITIALLY OBTAINED WITH NO RELAPSE OF THE NEW SEIZURE TYPE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PULSE GEN MODEL 100 LYJ CYBERONICS, INC. 100 C

Patients

Seq Age Sex Outcome Treatment
1 20 YR Required Intervention